| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $109.2M | $135.9M | $176.7M |
| YoY Revenue Growth % | -19.6% | -23.1% | — |
| Gross Profit | $33.6M | $46.9M | — |
| Gross Margin % | 30.8% | 34.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$16.4M | -$19.5M | -$26.3M |
| Operating Margin % | -15.0% | -14.3% | -14.9% |
| Net Income (GAAP) | -$23.8M | -$28.3M | -$39.2M |
| EBITDA (Normalized) | -$16.3M | -$19.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$3.3M | -$439.0K | $11.6M |
| Capital Expenditures (CapEx) | $102.0K | $506.0K | — |
| Free Cash Flow (FCF) | -$3.4M | -$945.0K | $11.6M |
| FCF Margin % | -3.1% | -0.7% | 6.6% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $9.4M | $8.0M | — |
| Total Debt (Short + Long Term) | $32.9M | $0 | — |
| Total Stockholders' Equity | $1.3M | -$12.9M | — |